David Carty

ORCID: 0000-0003-2475-0239
Publications
Citations
Views
---
Saved
---
About
Contact & Profiles
Research Areas
  • Pregnancy and preeclampsia studies
  • Birth, Development, and Health
  • Pituitary Gland Disorders and Treatments
  • Neuroendocrine Tumor Research Advances
  • Diabetes Management and Research
  • Adrenal and Paraganglionic Tumors
  • Gestational Diabetes Research and Management
  • Thyroid Disorders and Treatments
  • Pancreatic function and diabetes
  • Neuroblastoma Research and Treatments
  • Cardiovascular Health and Disease Prevention
  • Diabetes and associated disorders
  • Advanced Proteomics Techniques and Applications
  • Hormonal Regulation and Hypertension
  • Atherosclerosis and Cardiovascular Diseases
  • Metabolomics and Mass Spectrometry Studies
  • Lung Cancer Research Studies
  • Growth Hormone and Insulin-like Growth Factors
  • Diabetes Treatment and Management
  • Thyroid Cancer Diagnosis and Treatment
  • Diabetes, Cardiovascular Risks, and Lipoproteins
  • Pancreatitis Pathology and Treatment
  • Neonatal Respiratory Health Research
  • Cancer, Hypoxia, and Metabolism
  • IgG4-Related and Inflammatory Diseases

Glasgow Royal Infirmary
2013-2024

University of Glasgow
2013-2024

University of Edinburgh
2022

Sir Charles Gairdner Hospital
2020

Erasmus MC
2020

Biogipuzkoa Health Research Institute
2020

Queen Mary University of London
2020

William Harvey Research Institute
2020

Birmingham City Hospital
2019

Royal Berkshire Hospital
2019

Pregnant women with type 1 diabetes are a high-risk population who recommended to strive for optimal glucose control, but neonatal outcomes attributed maternal hyperglycaemia remain suboptimal. Our aim was examine the effectiveness of continuous monitoring (CGM) on control and obstetric health outcomes.In this multicentre, open-label, randomised controlled trial, we recruited aged 18-40 years minimum 12 months were receiving intensive insulin therapy. Participants pregnant (≤13 weeks 6 days'...

10.1016/s0140-6736(17)32400-5 article EN cc-by The Lancet 2017-09-15

10.1016/s2213-8587(17)30194-8 article EN publisher-specific-oa The Lancet Diabetes & Endocrinology 2017-06-11

Preeclampsia is a major determinant of fetal and maternal morbidity mortality. We used proteomic strategy to identify urinary biomarkers that predict preeclampsia before the onset disease. prospectively collected urine samples from women throughout pregnancy. Samples gestational weeks 12 16 (n=45), 20 (n=50), 28 (n=18) who subsequently had develop were matched controls (n=86, n=49, n=17, respectively). performed capillary electrophoresis online coupled micro-time-of-flight mass spectrometry....

10.1161/hypertensionaha.110.164285 article EN Hypertension 2011-01-04

OBJECTIVE To compare glycemic control, quality of life, and pregnancy outcomes women using insulin pumps multiple daily injection therapy (MDI) during the Continuous Glucose Monitoring in Women With Type 1 Diabetes Pregnancy Trial (CONCEPTT). RESEARCH DESIGN AND METHODS This was a prespecified analysis CONCEPTT involving 248 pregnant from 31 centers. Randomization stratified for pump versus MDI HbA1c. The primary outcome change HbA1c randomization to 34 weeks’ gestation. Key secondary were...

10.2337/dc18-1437 article EN Diabetes Care 2018-10-16

OBJECTIVE To determine if temporal glucose profiles differed between 1) women who were randomized to real-time continuous monitoring (RT-CGM) or self-monitored blood (SMBG), 2) used insulin pumps multiple daily injections (MDIs), and 3) whose infants born large for gestational age (LGA) not, by assessing CGM data obtained from the Continuous Glucose Monitoring in Women With Type 1 Diabetes Pregnancy Trial (CONCEPTT). RESEARCH DESIGN AND METHODS Standard summary metrics functional analysis...

10.2337/dc19-2527 article EN Diabetes Care 2020-03-24
Pedro Marques Francisca Caimari Laura C. Hernández‐Ramírez David Collier Donato Iacovazzo and 95 more Amy Ronaldson Kesson Magid Chung Thong Lim Karen Stals Sian Ellard Ashley Grossman Márta Korbonits Prakash Abraham Elena Daniela Aflorei Amar Agha James Ahlquist Scott Akker Krystallenia Alexandraki Sándor Alföldi João Anselmo Wiebke Arlt Brew Atkinson Anna Aulinas-Masó Simon Aylwin Atik Baborie Philippe Backeljauw Corin Badiu Stephanie Baldeweg Steve Ball Gul Bano Ariel Barkan John Barton Julian Barwell P. C. Bates Carmen Bernal-González Michael Besser John S. Bevan Alex Bickerton Joanne Blair Marek Bolanowski Pierre Bouloux Lisa Bradley Karin Bradley Caroline Brain Antonia Brooke Roger Brown Michael Buchfelder Christine Burren Mehtap Çakır Natalie Canham Joël Capraro Paul Carroll Philippa Carter David Carty Dominic Cavlan Harvinder Chahal Tim Cheetham F. Chentli Catherine S. Choong Mirjam Christ‐Crain Teng‐Teng Chung Peter Clayton Richard N. Clayton Mark L. Cohen Hamish Courtney David J. Cove Elizabeth Crowne Daniel J. Cuthbertson Jacob Dal Nadezhda Dalantaeva Svetozar Damjanović Christina Daousi Ken Darzy Mehul Dattani Michaela Davies Justin Davies J.R. Davis Margaret de Castro Laura De Marinis Cheri Deal Judit Dénes Paul Dimitri Neil Dorward Graham Dow William Drake Maralyn Druce Juliana Drummond Pinaki Dutta Larisa Dzeranova Britt Edén Engström Rosalind A. Eeles Maria Elfving Kate Ellis Marianne S. Elston Louise Emmerson Shereen Ezzat Naomi Fersht Simona Fica Stefan Fischli Maria Fleseriu

Abstract Context Germline mutations in the aryl hydrocarbon receptor-interacting protein (AIP) gene are responsible for a subset of familial isolated pituitary adenoma (FIPA) cases and sporadic neuroendocrine tumors (PitNETs). Objective To compare prospectively diagnosed AIP mutation-positive (AIPmut) PitNET patients with clinically presenting to clinical characteristics AIPmut AIPneg patients. Design 12-year prospective, observational study. Participants & Setting We studied probands...

10.1210/clinem/dgaa040 article EN cc-by The Journal of Clinical Endocrinology & Metabolism 2020-01-30

The CONCEPTT trial compared real-time Continuous Glucose Monitoring (RT-CGM) to capillary glucose monitoring in pregnant women with type 1 diabetes. We analyzed CGM and glycated hemoglobin (HbA1c) measures first (n = 221), second 197), third 172) trimesters, aiming examine target attainment associations pregnancy outcomes. targets were Time-in-range (TIR) > 70%, Time-above-range (TAR) <25%, Time-below-range (TBR) < 4%, HbA1c 6.5% (National Institute for Health Care Excellence [NICE]) 6.0%...

10.1089/dia.2021.0073 article EN Diabetes Technology & Therapeutics 2021-05-04

Pregnant women with type 1 diabetes strive for tight glucose targets (3.5-7.8 mmol/L) to minimise the risks of obstetric and neonatal complications. Despite using technologies including continuous monitoring (CGM), insulin pumps contemporary analogues, most struggle achieve maintain recommended pregnancy targets. This study aims evaluate whether use automated closed-loop delivery improves antenatal levels in pregnant diabetes.A multicentre, open label, randomized, controlled trial a HbA1c...

10.1186/s12884-022-04543-z article EN cc-by BMC Pregnancy and Childbirth 2022-04-05

Preeclampsia is a multisystem disease that significantly contributes to maternal and foetal morbidity mortality. In this study, we used nonbiased microarray approach identify novel circulating miRNAs in plasma may be associated with preeclampsia.Plasma samples were obtained at 16 28 weeks of gestation from 18 women who later developed preeclampsia (cases) matched normotensive pregnancies (controls). We studied miRNA expression profiles subsequently confirmed target gene placenta samples....

10.1097/hjh.0000000000000656 article EN Journal of Hypertension 2015-07-11

Circulating biomarkers of endothelial dysfunction and inflammation are elevated in late pregnancy women with preeclampsia. We examined plasma levels inflammatory cytokines adhesion molecules early pregnancy, to assess their ability predict preeclampsia.In a prospective longitudinal study, 2600 singleton pregnancies no history hypertension were recruited at antenatal hospital (booking) visit gestational week 12-16. Of these, 49 (1.9%) developed preeclampsia, whereas 74 matched for age BMI...

10.1097/hjh.0b013e328352573b article EN Journal of Hypertension 2012-03-22

We have previously described a panel of 238 urinary polypeptides specific for established severe coronary artery disease (CAD). Here we studied this polypeptide in patients with wider range CAD severity. recruited 60 who underwent elective angiography investigation stable angina. Patients were selected either having angiographic evidence or not (NCA) following (n = 30/30; age, 55 ± 6 vs. 56 7 years, P 0.539) to cover the extremes spectrum. A further 66 (age, 64 9 years) prior surgical...

10.1186/s12872-016-0246-y article EN cc-by BMC Cardiovascular Disorders 2016-04-19

Endothelial dysfunction is known to play a key role in the pathogenesis of preeclampsia, but majority methods for its detection are too invasive be used pregnancy. In this study we report novel method - peripheral arterial tonometry (PAT) examining microcirculatory function pregnancy.One hundred and eighty women with at least two risk factors preeclampsia were examined gestational weeks 16 28; 80 6-9 months postnatally. Twenty-four developed or pregnancy-induced hypertension (cases), 156...

10.1097/hjh.0b013e32834d76fb article EN Journal of Hypertension 2011-11-03

Summary Background Patients with fractures should be prioritized for assessment osteoporosis so that they can benefit from treatment the secondary prevention of osteoporotic fractures. Assessment is seldom offered to patients vertebral because these are typically not diagnosed. Vertebral identified by fracture (VFA) using current dual‐energy X‐ray absorptiometry (DXA) scanners. Objective The purpose this study was assess prevalence fractures, VFA, in presenting nonvertebral and whether...

10.1111/j.1365-2265.2007.02988.x article EN Clinical Endocrinology 2007-08-29
Coming Soon ...